Group urges Congress to create ‘overdue’ definition of LTC pharmacy
Published by McKnight’s
Differing definitions of long-term care pharmacies used by government agencies may threaten seniors’ care and disrupt care coordination, according to a leading long-term care pharmacy group.
In a policy brief released Monday, the Senior Care Pharmacy Coalition urged Congress and other regulatory authorities to adopt a “statutory, legislative” definition of long-term care pharmacies in order to ensure consistency across care settings for the more than 1.4 million Americans receiving the pharmacies’ services.
Currently the Centers for Medicare & Medicaid Services uses the “most comprehensive” definition of long-term care pharmacy, while the definitions used by the Environmental Protection Agency and the Food and Drug Administration are “far less concise,” SCPC said.
The policy brief also encourages Congress to address the “rapidly diversifying LTC marketplace,” and how LTC pharmacies should “operate in a future driven by diverse value-based purchasing models of [healthcare] delivery.”
SCPC will follow up the policy brief later this year with a potential definition of long-term care pharmacy for regulators to consider, said Alan Rosenbloom, president and CEO of SCPC.
“The range of activist federal agencies seeking to regulate LTC pharmacies today demands that Congress adopt a clear, statutory definition that explicitly identifies the unique and specific service offerings that LTC pharmacies provide,” Rosenbloom said. “Only by doing so can federal laws appropriately — and consistently — apply to the practice of LTC pharmacy, particularly in the face of a growing need for LTC services in our rapidly evolving [healthcare] delivery system.”
Click here to see the original article on the McKnight’s website.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.